Cargando…

Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients

Detalles Bibliográficos
Autores principales:	Sakamoto, Y, Mashiko, K, Matsumoto, H, Hara, Y, Kutsukata, N, Takei, K, Ueno, Y, Tomita, Y, Yamamoto, Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092666/ http://dx.doi.org/10.1186/cc4638

Ejemplares similares

Increase in systolic blood pressure and improvement in laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock
por: Sakamoto, Y, et al.
Publicado: (2010)

Relationship between the use of polymyxin B-immobilized fiber for hemofiltration and some laboratory parameters (endocannabinoids, high mobility group box-1 protein and oxidative stress) in severe pneumonia patients
por: Mashiko, K, et al.
Publicado: (2008)

Mechanism and effectiveness of polymyxin B-immobilized fiber columns for removing mediators (HMBG-1, 2-arachidonoyl glycerol, anandamide, PAI-1, protein C and IL-6) in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2007)

Best choice of acute blood purification therapy based on the severity score and blood lactic acid values in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2009)

Effectiveness of early start of direct hemoperfusion with polymyxin B-immobilized fiber columns judging from stabilization in circulatory dynamics in surgical treatment patients
por: Sakamoto, Yuichiro, et al.
Publicado: (2010)

Examination of the utility of serum lactate and base deficit in hemorrhagic shock
por: Jonishi, K, et al.
Publicado: (2010)

Removing endocannabinoids and reducing oxidative stress with polymyxin-B-immobilized fibers in patients with septic shock
por: Kase, Y, et al.
Publicado: (2007)

Clinical efficacy of long-term performance with polymyxin-B immobilized fiber treatment for septic shock
por: Matumoto, N, et al.
Publicado: (2008)

Extended duration of direct hemoperfusion with polymyxin B-immobilized fiber column improves hemodynamics in patients with septic shock
por: Yamashita, C, et al.
Publicado: (2011)

Relationship between the presence of serum high-mobility-group box protein 1 and the injury severity score in trauma patients
por: Sakamoto, Y, et al.
Publicado: (2007)

Effectiveness of polymyxin b immobilized fiber hemoperfusion in patients with septic shock due to Gram-negative bacillus infection: the PMXHP study
por: Saito, N, et al.
Publicado: (2015)

Effectiveness of continuous venovenous hemodiafiltration using a polymethylmethacrylate membrane hemofilter in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2008)

Observational study for direct hemoperfusion therapy with polymyxin-B immobilized fibers (PMX-DHP) in patients with septic shock in Japan: PMX-DHP study group
por: Kase, Y, et al.
Publicado: (2009)

Selection of acute blood purification therapy according to severity score and blood lactic acid value in patients with septic shock
por: Sakamoto, Yuichiro, et al.
Publicado: (2010)

High mobility group box 1 levels in septic disseminated intravascular coagulation patients undergoing Polymixin-B immobilized fiber-direct hemoperfusion
por: Ishibe, Y, et al.
Publicado: (2012)

Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock
por: Sugiura, Makiko, et al.
Publicado: (2015)

Effectiveness of continuous venovenous hemodiafiltration using a polymethylmethacrylate membrane hemofilter judging from a multiplex suspension array system in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2011)

Re-evaluation of direct hemoperfusion with polymyxin-B immobilized fiber for severe sepsis and septic shock
por: Matsuo, SM, et al.
Publicado: (2011)

Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock
por: Shoji, Hisataka, et al.
Publicado: (2021)

Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock
por: Mitaka, Chieko, et al.
Publicado: (2021)

Beneficial effects of early hemoperfusion with a polymyxin B fibre column on septic shock
por: Takeyama, N, et al.
Publicado: (2009)

Investigation of type II phospholipase A(2 )values and eicosanoid values during polymyxin-B-immobilized fiber direct hemoperfusion of septic shock patients
por: Shouzushima, T, et al.
Publicado: (2009)

Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection
por: Saito, Nobuyuki, et al.
Publicado: (2017)

History and current status of polymyxin B‐immobilized fiber column for treatment of severe sepsis and septic shock
por: Shimizu, Tomoharu, et al.
Publicado: (2017)

Serum high-mobility group box-1 protein as a specific marker of severe abdominal injury
por: Sakamoto, Y, et al.
Publicado: (2009)

Effects of endotoxin elimination therapy using polymyxin B immobilized fiber in patients with septic shock after surgical operation
por: Ikeda, T, et al.
Publicado: (1997)

Does early appropriate antibiotic therapy improve the outcome of severe sepsis or septic shock?
por: Saito, N, et al.
Publicado: (2009)

A simple predictive scoring system for prolonged mechanical ventilation in severe sepsis and septic shock
por: Saito, N, et al.
Publicado: (2010)

Is polymyxin B-immobilized fiber column ineffective for septic shock? A discussion on the press release for EUPHRATES trial
por: Iba, Toshiaki, et al.
Publicado: (2017)

A successful application of adult polymyxin B-immobilized fiber column hemoperfusion to a neonate with septic shock
por: Kim, Young A, et al.
Publicado: (2019)

Prognostic factors in patients with septic shock in digestive surgery who have undergone direct hemoperfusion with polymyxin B-immobilized fibers: a retrospective observational study
por: Matsukuma, Satoshi, et al.
Publicado: (2015)

Clinical effects of polymyxin B immobilised fiber with direct hemoperfusion for the patients of severe sepsis or septic shock caused by intra-abdominal infections
por: Ikeda, T, et al.
Publicado: (2009)

Selection of acute blood purification therapy according to lipid mediator adsorption and blood purification in patients with septic shock
por: Sakamoto, Y, et al.
Publicado: (2010)

Procalcitonin level as a marker of severe sepsis and septic shock patients who required polymyxin-B immobilized fiber with direct hemoperfusion
por: Ikeda, T, et al.
Publicado: (2012)

Apheresis of activated leukocytes with an immobilized polymyxin B filter
por: Takeyama, N, et al.
Publicado: (2010)

Use of Direct Hemoperfusion with Polymyxin B-Immobilized Fiber for the Treatment of Septic Shock Complicated with Lemierre Syndrome Caused by Fusobacterium necrophorum
por: Kodama, Yoshiyuki, et al.
Publicado: (2019)

Polymyxin B-immobilized fiber column hemoperfusion has the ability of endotoxin removal during 24 hours
por: Mitaka, C, et al.
Publicado: (2012)

White blood cell counts have an impact on septic patient outcome followed by polymyxin-b immobilized fiber with direct hemoperfusion
por: Tanaka, H, et al.
Publicado: (2015)

“Impact of timing of polymyxin B‐immobilized fiber column direct hemoperfusion on outcome in patients with septic shock: a single‐center observational study”
por: Tanaka, Tomoki, et al.
Publicado: (2019)

The effect of polymixin B immobilized on fibers and continuous veno-venous hemodiafiltration on tetrahydrobiopterine and NO metabolites in septic patients
por: Kakihana, Y, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_7gto4ttgtdnk0ei54jpi1pupru